x

Posted 12 September, 2022

Ventas, Inc. appointed new CEO

CEO Change detected for ticker NYSE:VTR in a 8-K filed on 12 September, 2022.


  On September 12, 2022, Sumit Roy, President & Chief Executive Officer at Realty Income Corporation, was appointed as an independent director to the Board of Directors (the "Board") of Ventas, Inc. ("we," "us," "our," "Company" and other similar terms) effective October 1, 2022.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Ventas, Inc.
Real Estate/Construction • Healthcare REITs
Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. It operates through the following segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio (OM&R), and Triple-net Leased Properties (NNN). The SHOP segment is involved in owning and investing in senior housing communities throughout the United States and Canada. The OM&R segment refers to acquiring, owning, development, leasing and managing outpatient medical buildings and research centers throughout the United States. The NNN segment focuses on investing and owning senior housing communities, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities, and other healthcare facilities throughout the United States and the United Kingdom. The company was founded in 1983 and is headquartered in Chicago, IL.
Market Cap
$31.6B
View Company Details
Ventas, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On September 12, 2022, Sumit Roy, President & Chief Executive Officer at Realty Income Corporation, was appointed as an independent director to the Board of Directors (the "Board") of Ventas, Inc. ("we," "us," "our," "Company" and other similar terms) effective October 1, 2022.


Mr. Roy is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Roy and any other persons pursuant to which he was selected as a director. Mr. Roy will serve on the Investment Committee of the Board. Mr. Roy will participate in the compensation arrangements for non-employee directors, including receiving an initial award of shares of restricted stock upon appointment, as described in the Company's 2022 proxy statement filed with the U.S. Securities and Exchange Commission on March 29, 2022.


On September 12, 2022, Robert D. Reed, a director of the Company, advised the Board that he will not stand for re-election as a director of the Company at the 2023 annual meeting of stockholders. Mr. Reed currently serves as a member of the Nominating, Governance and Corporate Responsibility Committee and Investment Committee of the Board. Mr. Reed's decision not to stand for re-election did not involve any disagreement with the Company on any matter relating to the Company's operations, policies or practices.